Candel Therapeutics announces inducement grants under Nasdaq Rule 5635(c)(4)
Candel Therapeutics (CADL) announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
Story updates
08:07:49 PM UTC
SquawkNews
NEEDHAM, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) NASDAQ:CADL, a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on August 31, 2026…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.